Despite strong clinical data, RSV immunization rates among pregnant women and older adults remain worryingly low, ...

The risk for respiratory syncytial virus-related hospitalizations is elevated in children with chronic medical conditions ...

And while 2023 brought the development of a monoclonal antibody for infants, a type of passive immunization that provides short-term protection from RSV, there has yet to be an actual RSV vaccine for ...

Indian hospitals witness a surge in infant respiratory infections during monsoon and winter, often due to Respiratory ...

Hospital readmission risk in pediatric patients was higher in those who were first admitted for RSV than in those who were first admitted for influenza or hMPV.

Rehospitalization for RSV within the same season was rare, suggesting limited need for routine additional monoclonal antibody ...

The eight new ACIP members met for the first time June 25 after Kennedy fired all 17 original members of the committee June 9 ...

A new antibody shot that protects babies against RSV infection could be struggling to gain traction, Philadelphia researchers ...

Young children with chronic conditions are more likely to be hospitalized for respiratory syncytial virus (RSV) than healthy children, according to a new study. The research will be presented at ...

Fiance's Annie Suwan and David Toborowsky shared an emotional update on their infant daughter Minthirarad's hospitalization for RSV ...

Enanta Pharmaceuticals Announces Data from its Phase 2 Study of Zelicapavir in Children with Respiratory Syncytial Virus to be Presented at the 43 rd Annual ESPID Meeting. Enanta Pharmaceuticals ...

Enanta’s clinical programs are currently focused on respiratory syncytial virus (RSV) and its earlier-stage immunology pipeline aims to develop treatments for inflammatory diseases by targeting ...